T1D: Artificial pancreas keeps glucose in range for longer

Trial comparing a closed loop device with a sensor-augmented pump shows benefits of new algorithm

Patients with type 1 diabetes who use an experimental closed-loop artificial pancreas device have blood sugar levels within a target range for longer than those who use a sensor-augmented insulin pump, a study shows.